GURUFOCUS.COM » STOCK LIST » USA » NAS » CME Group Inc (NAS:CME) » Definitions » EV-to-EBITDA
Switch to:

CME Group EV-to-EBITDA

: 17.62 (As of Today)
View and export this data going back to 2002. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CME Group's enterprise value is $74,284 Mil. CME Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was $4,217 Mil. Therefore, CME Group's EV-to-EBITDA for today is 17.62.

The historical rank and industry rank for CME Group's EV-to-EBITDA or its related term are showing as below:

CME' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.99   Med: 15.24   Max: 26.09
Current: 17.62

During the past 13 years, the highest EV-to-EBITDA of CME Group was 26.09. The lowest was 3.99. And the median was 15.24.

CME's EV-to-EBITDA is ranked worse than
69.01% of 426 companies
in the Capital Markets industry
Industry Median: 9.11 vs CME: 17.62

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2022-08-15), CME Group's stock price is $202.60. CME Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $8.060. Therefore, CME Group's PE Ratio for today is 25.14.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


CME Group EV-to-EBITDA Historical Data

The historical data trend for CME Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.46 22.02 22.12 19.96 20.99

CME Group Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.92 19.31 20.99 21.20 17.76

Competitive Comparison

For the Financial Data & Stock Exchanges subindustry, CME Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

CME Group EV-to-EBITDA Distribution

For the Capital Markets industry and Financial Services sector, CME Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CME Group's EV-to-EBITDA falls into.



CME Group EV-to-EBITDA Calculation

CME Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=74283.922/4217
=17.62

CME Group's current Enterprise Value is $74,284 Mil.
CME Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,217 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CME Group  (NAS:CME) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CME Group's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=202.60/8.060
=25.14

CME Group's share price for today is $202.60.
CME Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.060.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


CME Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CME Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CME Group Business Description

CME Group logo
Address
20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P/Dow Jones Indices LLC, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
Executives
Mccourt Timothy Francis officer: Sr MD Global Head Equity & FX 20 S WACKER DRIVE CHICAGO IL 60606
Fitzpatrick Lynne officer: Sr MD Deputy CFO 20 S WACKER DRIVE CHICAGO IL 60606
Sprague Suzanne officer: Sr MD Global Head of Clearing 20 SOUTH WACKER DRIVE 18S CHICAGO IL 60606
Dennis Michael G. director 20 S. WACKER DR. CHICAGO IL 60606
Maloney Patrick W director 20 S. WACKER DR. CHICAGO IL 60201
Mulchrone Patrick J director 20 S. WACKER DR. CHICAGO IL 60606
Seifu Rahael director 20 S. WACKER CHICAGO IL 60606
Harris Yra G director 20 S. WACKER DR CHICAGO IL 60606
Lockett Phyllis M director 20 S. WACKER DR. CHICAGO IL 60606
Tierney Robert J Jr director 20 S. WACKER DR. CHICAGO IL 60606
Kaye Daniel G director 1742 APPLEBY ROAD INVERNESS IL 60067
Spencer Michael A director 20 S. WACKER DR. CHICAGO IL 60606
Lucas Deborah J director C/O ANTHRACITE CAPITAL, INC. 40 EAST 52ND STREET NEW YORK NY 10022
Hertshten Gedon director 20 S. WACKER DR. CHICAGO IL 60606
Winkler Julie officer: Chief Commercial Officer 20 S. WACKER DR. CHICAGO IL 60606

CME Group Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)